EUROPE SINGLE CELL ANALYSIS MARKET FORECAST 2017-2025
KEY FINDINGS
The European single cell market with a growing CAGR of 19.42 % was estimated to be worth $404 million in 2016 and is expected to reach up to $1890 million by 2025.Increasing opportunity in cancer cell research, development of innovative modalities, growing aged populace, booming biopharmaceutical and biotechnology industries and rising subsidy for cell research by the government are some of the key drivers for the growth of the single cell market.
MARKET INSIGHTS
The countries analyzed for the European single cell market include United Kingdom, France, Spain, Germany, Italy and Rest of Europe. The two major applications of single cell analysis in the market are in the field of research and medicine. The research applications in the market are further subdivided into areas like Immunology Market, Cancer Market, Stem Cells Market, Neurology Market, Stem Cells Market, and other research applications market. The medical applications are subdivided into Non-invasive prenatal diagnosis market, circular tumor cells (CTCS) market and In-vitro fertilization (IVF) market. However, with an expected CAGR of 19.72 % between 2016 to 2025, the research application is expected to be more dominant. In terms of products, the market is divided into consumables and instruments. Also, the human cells market holds a major market share by Cell type as compared to animal cell market, which is also now fast growing
COMPETITIVE INSIGHTS
The leading companies in the Single-cell analysis market are Stem Cell Technologies, Thermo Fisher Scientific Inc, GE Healthcare, Nanostring Technologies Inc, Beckman colter Inc, Beckton Dickinson and company, Stryke Corporation, Medtronic’s plc, Miltenyi Biotec, Celgene Corporation, and Agilent Technology Inc. GE Healthcare has the largest market share in the single cell market as compared to rest of the companies closely followed by Stem cell technologies.
The European single cell market with a growing CAGR of 19.42 % was estimated to be worth $404 million in 2016 and is expected to reach up to $1890 million by 2025.Increasing opportunity in cancer cell research, development of innovative modalities, growing aged populace, booming biopharmaceutical and biotechnology industries and rising subsidy for cell research by the government are some of the key drivers for the growth of the single cell market.
MARKET INSIGHTS
The countries analyzed for the European single cell market include United Kingdom, France, Spain, Germany, Italy and Rest of Europe. The two major applications of single cell analysis in the market are in the field of research and medicine. The research applications in the market are further subdivided into areas like Immunology Market, Cancer Market, Stem Cells Market, Neurology Market, Stem Cells Market, and other research applications market. The medical applications are subdivided into Non-invasive prenatal diagnosis market, circular tumor cells (CTCS) market and In-vitro fertilization (IVF) market. However, with an expected CAGR of 19.72 % between 2016 to 2025, the research application is expected to be more dominant. In terms of products, the market is divided into consumables and instruments. Also, the human cells market holds a major market share by Cell type as compared to animal cell market, which is also now fast growing
COMPETITIVE INSIGHTS
The leading companies in the Single-cell analysis market are Stem Cell Technologies, Thermo Fisher Scientific Inc, GE Healthcare, Nanostring Technologies Inc, Beckman colter Inc, Beckton Dickinson and company, Stryke Corporation, Medtronic’s plc, Miltenyi Biotec, Celgene Corporation, and Agilent Technology Inc. GE Healthcare has the largest market share in the single cell market as compared to rest of the companies closely followed by Stem cell technologies.
1. RESEARCH SCOPE
1.1. STUDY GOAL
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. KEY FINDINGS
4. MARKET OVERVIEW
4.1. DRIVERS
4.1.1. EXPANDING TECHNOLOGICAL INNOVATIONS
4.1.2. EXPANDING OCCURRENCE OF TRANSMITTABLE INFECTIONS ACROSS THE GLOBE
4.1.3. GROWING AGED POPULACE
4.1.4. GROWING BIOPHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY
4.1.5. RISING GOVERNMENT SUBSIDY FOR RESEARCH
4.2. RESTRAINTS
4.2.1. LARGE PRIMARY COST DISCOURAGING INVESTMENT
4.2.2. CONCERNS ASSOCIATED WITH INTELLECTUAL PROPERTY AND PATENTS RIGHTS
4.3. MARKET OPPORTUNITY
4.3.1. SINGLE-CELL SEQUENCING (SCS) PROCESS BEING INCREASING USED IN DNA AND RNA ANALYSIS
4.3.2. DEVELOPMENT OF INNOVATIVE MODALITIES
4.3.3. SINGLE-CELL SEQUENCING (SCS) PROCESS BEING INCREASING USED IN DNA AND RNA ANALYSIS
4.3.4. INCREASING INVESTMENT MADE BY THE ASIAN COUNTRIES
4.3.5. ENHANCE OPPORTUNITY IN CANCER CELL RESEARCH
4.4. CHALLENGES
4.4.1. LACK OF ADEQUATE INFRASTRUCTURE
4.4.2. DELAYED ADOPTION OF SINGLE CELL TECHNOLOGY
5. MARKET SEGMENTATION
5.1. BY APPLICATION
5.1.1. MEDICAL APPLICATIONS MARKET
5.1.1.1. CIRCULAR TUMOUR CELLS (CTCS) MARKET
5.1.1.2. NON-INVASIVE PRENATAL DIAGNOSIS MARKET
5.1.1.3. IN VITRO FERTILIZATION (IVF) MARKET
5.1.2. RESEARCH APPLICATIONS MARKET
5.1.2.1. CANCER MARKET
5.1.2.2. IMMUNOLOGY MARKET
5.1.2.3. NEUROLOGY MARKET
5.1.2.4. STEM CELLS MARKET
5.1.2.5. OTHER RESEARCH APPLICATIONS MARKET
5.2. BY TECHNIQUE
5.2.1. FLOW CYTOMETRY MARKET
5.2.2. MASS SPECTROMETRY MARKET
5.2.3. MICROSCOPY MARKET
5.2.3.1. NEXT-GENERATION SEQUENCING (NGS) MARKET
5.2.3.2. PCR (POLYMERASE CHAIN REACTION) MARKET
5.2.3.3. OTHER TECHNIQUES MARKET
5.3. BY CELL TYPE
5.3.1. ANIMAL CELLS MARKET
5.3.2. HUMAN CELLS MARKET
5.3.3. MICROBIAL CELLS MARKET
5.4. BY END USER
5.4.1. BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET
5.4.2. CELL BANKS AND IVF CENTERS MARKET
5.4.3. HOSPITALS AND DIAGNOSTICS LABORATORIES MARKET
5.4.4. RESEARCH & ACADEMIC LABORATORIES MARKET
5.5. BY PRODUCT
5.5.1. CONSUMABLE MARKET
5.5.1.1. ASSAY KITS MARKET
5.5.1.2. BEADS MARKET
5.5.1.3. MICRO PLATES MARKET
5.5.1.4. REAGENTS MARKET
5.5.1.5. OTHER CONSUMABLES MARKET
5.5.2. INSTRUMENT MARKET
5.5.2.1. CELL COUNTER MARKET
5.5.2.2. CELL MICROARRAYS MARKET
5.5.2.3. FLOW CYTOMETERS MARKET
5.5.2.4. HCS SYSTEMS MARKET
5.5.2.5. MICROSCOPES
5.5.2.6. OTHER INSTRUMENTS
6. KEY ANALYTICS
6.1. PORTER’S FIVE FORCE MODEL
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE PRODUCT
6.1.3. BARGAINING POWER OF BUYERS
6.1.4. BARGAINING POWER OF SUPPLIERS
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. PESTEL ANALYSIS
6.3. OPPORTUNITY MATRIX
6.4. KEY BUYING CRITERIA
6.4.1. PRICING
6.4.2. EFFICACY
6.4.3. ACCURACY
6.4.4. APPLICATION AND EFFECTIVENESS
6.5. STRATEGIC RECOMMENDATION & STRATEGIC CONCLUSIONS
6.6. VENDOR LANDSCAPE
6.7. VALUE CHAIN ANALYSIS
7. REGIONAL ANALYSIS
7.1. EUROPE SINGLE CELL ANALYSIS MARKET
7.1.1. UNITED KINGDOM (UK) SINGLE CELL ANALYSIS MARKET
7.1.2. FRANCE SINGLE CELL ANALYSIS MARKET
7.1.3. GERMANY SINGLE CELL ANALYSIS MARKET
7.1.4. SPAIN SINGLE CELL ANALYSIS MARKET
7.1.5. ITALY SINGLE CELL ANALYSIS MARKET
7.1.6. ROE SINGLE CELL ANALYSIS MARKET
8. COMPETITIVE LANDSCAPE
8.1. MARKET SHARE ANALYSIS
8.2. TOP WINNING STRATEGIES
9. COMPANY PROFILES
9.1. CORNING INC.
9.1.1. OVERVIEW
9.1.2. PRODUCT PORTFOLIO
9.1.3. SCOT ANALYSIS
9.1.4. STRATEGIC ANALYSIS
9.2. CELGENE CORPORATION
9.2.1. OVERVIEW
9.2.2. PRODUCT PORTFOLIO
9.2.3. STRATEGIC INITIATIVES
9.2.4. SCOT ANALYSIS
9.2.5. STRATEGIC ANALYSIS
9.3. ILLUMINA INC.
9.3.1. OVERVIEW
9.3.2. PRODUCT PORTFOLIO
9.3.3. STRATEGIC INITIATIVE
9.3.4. SCOT ANALYSIS
9.3.5. STRATEGIC ANALYSIS
9.4. MILTENYI BIOTEC
9.4.1. OVERVIEW
9.4.2. PRODUCT PORTFOLIO
9.4.3. STRATEGIC INITIATIVES
9.4.4. SCOT ANALYSIS
9.4.5. STRATEGIC ANALYSIS
9.5. NANOSTRING TECHNOLOGIESINC
9.5.1. OVERVIEW
9.5.2. PRODUCT PORTFOLIO
9.5.3. STRATEGIC INITIATIVE
9.5.4. SCOT ANALYSIS
9.5.5. STRATEGIC ANALYSIS
9.6. AGILENT TECHNOLOGY INC
9.6.1. OVERVIEW
9.6.2. PRODUCT PORTFOLIO
9.6.3. STRATEGIC INITIATIVESCOT
9.6.4. ANALYSIS
9.6.5. STRATEGIC ANALYSIS
9.7. GE HEALTHCARE
9.7.1. OVERVIEW
9.7.2. PRODUCT PORTFOLIO
9.7.3. STRATEGIC INITIATIVES
9.7.4. SCOT ANALYSIS
9.7.5. STRATEGIC ANALYSIS
9.8. BECKMAN COULTER, INC.
9.8.1. OVERVIEW
9.8.2. PRODUCT PORTFOLIO
9.8.3. SCOT ANALYSIS
9.8.4. STRATEGIC ANALYSIS
9.9. MEDTRONIC’S PLC
9.9.1. OVERVIEW
9.9.2. PRODUCT PORTFOLIO
9.9.3. STRATEGIC INITIATIVE
9.9.4. SCOT ANALYSIS
9.9.5. STRATEGIC ANALYSIS
9.10. STRYKER CORPORATION
9.10.1. OVERVIEW
9.10.2. PRODUCT PORTFOLIO
9.10.3. SCOT ANALYSIS
9.10.4. STRATEGIC ANALYSIS
9.11. THERMO FISHER SCIENTIFIC, INC.
9.11.1. OVERVIEW
9.11.2. PRODUCT PORTFOLIO
9.11.3. STRATEGIC INITIATIVE
9.11.4. SCOT ANALYSIS
9.11.5. STRATEGIC ANALYSIS
9.12. QIAGEN N V
9.12.1. OVERVIEW
9.12.2. PRODUCT PORTFOLIO
9.12.3. SCOT ANALYSIS
9.12.4. STRATEGIC ANALYSIS
9.13. BECKTON DICKINSON AND COMPANY
9.13.1. OVERVIEW
9.13.2. PRODUCT PORTFOLIO
9.13.3. SCOT ANALYSIS
9.13.4. STRATEGIC ANALYSIS
9.14. STEM CELL TECHNOLOGIES
9.14.1. OVERVIEW
9.14.2. PRODUCT PORTFOLIO
9.14.3. STRATEGIC INITIATIVES
9.14.4. SCOT ANALYSIS
9.14.5. STRATEGIC ANALYSIS
TABLE LIST
TABLE 1 EUROPE SINGLE CELL ANALYSIS MARKET BY APPLICATION 2017-2025($ MILLION)
TABLE 2 EUROPE SINGLE CELL ANALYSIS MARKET BY MEDICAL APPLICATIONS 2017-2025($ MILLION)
TABLE 3 EUROPE CTCS MARKET BY 2017-2025($ MILLION)
TABLE 4 EUROPE NIPT MARKET BY 2017-2025($ MILLION)
TABLE 5 EUROPE IVF MARKET BY 2017-2025($ MILLION)
TABLE 6 EUROPE SINGLE CELL ANALYSIS MARKET BY RESEARCH APPLICATIONS, 2017-2025($ MILLION)
TABLE 7 EUROPE SINGLE CELL ANALYSIS MARKET BY RESEARCH APPLICATIONS, 2017-2025($ MILLION)
TABLE 8 EUROPE CANCER MARKET BY 2017-2025($ MILLION)
TABLE 9 EUROPE IMMUNOLOGY MARKET BY 2017-2025($ MILLION)
TABLE 10 EUROPE NEUROLOGY MARKET BY 2017-2025($ MILLION)
TABLE 11 EUROPE STEM CELLS MARKET BY 2017-2025($ MILLION)
TABLE 12 EUROPE OTHER RESEARCH APPLICATIONS MARKET BY 2017-2025($ MILLION)
TABLE 13 EUROPE SINGLE CELL ANALYSIS MARKET BY TECHNIQUE 2017-2025($ MILLION)
TABLE 14 EUROPE FLOW CYTOMETRY MARKET BY 2017-2025($ MILLION)
TABLE 15 EUROPE MASS SPECTROMETRY MARKET BY 2017-2025($ MILLION)
TABLE 16 EUROPE MICROSCOPY MARKET 2017-2025($ MILLION)
TABLE 17 EUROPE MICROSCOPY MARKET BY 2017-2025($ MILLION)
TABLE 18 EUROPE NEXT GENERATION SEQUENCING MARKET BY 2017-2025($ MILLION)
TABLE 19 EUROPE PCR MARKET BY 2017-2025($ MILLION)
TABLE 20 EUROPE OTHER TECHNIQUES MARKET BY 2017-2025($ MILLION)
TABLE 21 EUROPE SINGLE CELL ANALYSIS MARKET BY CELL TYPE 2017-2025($ MILLION)
TABLE 22 EUROPE ANIMAL CELL MARKET 2017-2025($ MILLION)
TABLE 23 EUROPE HUMAN CELL MARKET 2017-2025($ MILLION)
TABLE 24 EUROPE MICROBIAL CELL MARKET 2017-2025($ MILLION)
TABLE 25 EUROPE BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET 2017-2025($ MILLION)
TABLE 26 EUROPE CELL BANKS AND IVF CENTERS MARKET 2017-2025($ MILLION)
TABLE 27 EUROPE HOSPITALS AND DIAGNOSTICS LABORATORIES MARKET 2017-2025($ MILLION)
TABLE 28 EUROPE RESEARCH & ACADEMIC LABORATORIES MARKET 2017-2025($ MILLION)
TABLE 29 EUROPE SINGLE CELL ANALYSIS MARKET BY PRODUCTS 2017-2025($ MILLION)
TABLE 30 EUROPE SINGLE CELL ANALYSIS BY CONSUMABLE MARKET 2017-2025($ MILLION)
TABLE 31 EUROPE SINGLE CELL ANALYSIS MARKET BY ASSAY KITS 2017-2025($ MILLION)
TABLE 32 EUROPE SINGLE CELL ANALYSIS MARKET BY BEADS 2017-2025($ MILLION)
TABLE 33 EUROPE SINGLE CELL ANALYSIS MARKET BY MICROPLATES 2017-2025($ MILLION)
TABLE 34 EUROPE SINGLE CELL ANALYSIS MARKET BY REAGENTS 2017-2025($ MILLION)
TABLE 35 EUROPE SINGLE CELL ANALYSIS MARKET BY OTHER CONSUMABLES 2017-2025($ MILLION)
TABLE 36 EUROPE SINGLE CELL ANALYSIS BY CONSUMABLE MARKET 2017-2025($ MILLION)
TABLE 37 EUROPE SINGLE CELL ANALYSIS MARKET BY CELL COUNTER 2017-2025($ MILLION)
TABLE 38 EUROPE SINGLE CELL ANALYSIS MARKET BY CELL MICROARRAY 2017-2025($ MILLION)
TABLE 39 EUROPE SINGLE CELL ANALYSIS MARKET BY FLOW CYTOMETRY 2017-2025($ MILLION)
TABLE 40 EUROPE SINGLE CELL ANALYSIS MARKET BY MICROSCOPES 2017-2025($ MILLION)
TABLE 41 EUROPE SINGLE CELL ANALYSIS MARKET BY OTHER INSTRUMENTS 2017-2025($ MILLION)
FIGURE LIST
FIGURE 1 EUROPE SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 2 MARKET BREAKUP BY REVENUE IN 2016
FIGURE 3 NIH SPENDING ON STEM CELL, BY YEARS (USD BILLIONS)
FIGURE 4 EUROPE SINGLE CELL ANALYSIS MARKET BY CTCS 2017-2025($ MILLION)
FIGURE 5 EUROPE SINGLE CELL ANALYSIS MARKET BY NIPT 2017-2025($ MILLION)
FIGURE 6 EUROPE SINGLE CELL ANALYSIS MARKET BY IVF 2017-2025($ MILLION)
FIGURE 7 EUROPE SINGLE CELL ANALYSIS MARKET BY CANCER 2017-2025($ MILLION)
FIGURE 8 EUROPE SINGLE CELL ANALYSIS MARKET BY IMMUNOLOGY 2017-2025($ MILLION)
FIGURE 9 EUROPE SINGLE CELL ANALYSIS MARKET BY NEUROLOGY 2017-2025($ MILLION)
FIGURE 10 EUROPE SINGLE CELL ANALYSIS MARKET BY STEM CELLS 2017-2025($ MILLION)
FIGURE 11 EUROPE SINGLE CELL ANALYSIS MARKET BY OTHER RESEARCH APPLICATIONS 2017-2025($ MILLION)
FIGURE 12 EUROPE SINGLE CELL ANALYSIS MARKET BY FLOW CYTOMETRY 2017-2025($ MILLION)
FIGURE 13 EUROPE SINGLE CELL ANALYSIS MARKET BY MASS SPECTROMETRY 2017-2025($ MILLION)
FIGURE 14 EUROPE SINGLE CELL ANALYSIS MARKET BY MICROSCOPY 2017-2025($ MILLION)
FIGURE 15 EUROPE SINGLE CELL ANALYSIS MARKET BY NEXT GENERATION SEQUENCING 2017-2025($ MILLION)
FIGURE 16 EUROPE SINGLE CELL ANALYSIS MARKET BY PCR 2017-2025($ MILLION)
FIGURE 17 EUROPE SINGLE CELL ANALYSIS MARKET BY OTHER TECHNIQUES 2017-2025($ MILLION)
FIGURE 18 EUROPE ANIMAL CELL MARKET 2017-2025($ MILLION)
FIGURE 19 EUROPE HUMAN CELL MARKET 2017-2025($ MILLION)
FIGURE 20 EUROPE NEW CANCER CASES AND MOTILITY RATE IN MILLION (2015-2030)
FIGURE 21 EUROPE MICROBIAL CELL MARKET 2017-2025($ MILLION)
FIGURE 22 EUROPE BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET 2017-2025($ MILLION)
FIGURE 23 EUROPE CELL BANKS AND IVF CENTERS MARKET
FIGURE 24 EUROPE HOSPITALS AND DIAGNOSTICS LABORATORIES MARKET 2017-2025($ MILLION)
FIGURE 25 EUROPE RESEARCH & ACADEMIC LABORATORIES MARKET 2017-2025($ MILLION)
FIGURE 26 EUROPE SINGLE CELL ANALYSIS MARKET BY ASSAY KITS 2017-2025($ MILLION)
FIGURE 27 EUROPE SINGLE CELL ANALYSIS MARKET BY BEADS 2017-2025($ MILLION)
FIGURE 28 EUROPE SINGLE CELL ANALYSIS MARKET BY MICROPLATES 2017-2025($ MILLION)
FIGURE 29 EUROPE SINGLE CELL ANALYSIS MARKET BY REGENTS 2017-2025($ MILLION)
FIGURE 30 EUROPE SINGLE CELL ANALYSIS MARKET BY OTHER CONSUMABLES 2017-2025($ MILLION)
FIGURE 31 EUROPE SINGLE CELL ANALYSIS MARKET BY CELL COUNTER 2017-2025($ MILLION)
FIGURE 32 EUROPE SINGLE CELL ANALYSIS MARKET BY CELL MICROARRAY 2017-2025($ MILLION)
FIGURE 33 EUROPE SINGLE CELL ANALYSIS MARKET BY FLOW CYTOMETRY 2017-2025($ MILLION)
FIGURE 34 EUROPE SINGLE CELL ANALYSIS MARKET BY HCS SYSTEM 2017-2025($ MILLION)
FIGURE 35 EUROPE SINGLE CELL ANALYSIS MARKET BY MICROSCOPES 2017-2025($ MILLION)
FIGURE 36 EUROPE SINGLE CELL ANALYSIS MARKET BY OTHER INSTRUMENTS 2017-2025($ MILLION)
FIGURE 37 REVENUE OF DIAGNOSTIC & MEDICAL LABORATORIES IN THE US, 2014-16 (BILLIONS)
FIGURE 38 NUMBER OF PEOPLE LIVING WITH HIV IN 2015 EUROPELY (MILLIONS)
FIGURE 39 UNITED KINGDOM SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 40 ESTIMATED WHO REGIONAL TB STATISTICS FOR 2015
FIGURE 41 FRANCE SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 42 GERMANY SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 43 PERCENTAGE OF PEOPLE OVER 65 YEARS OF AGE (SPAIN)
FIGURE 44 SPAIN SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 45 ITALY SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 46 ROE SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
1.1. STUDY GOAL
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. KEY FINDINGS
4. MARKET OVERVIEW
4.1. DRIVERS
4.1.1. EXPANDING TECHNOLOGICAL INNOVATIONS
4.1.2. EXPANDING OCCURRENCE OF TRANSMITTABLE INFECTIONS ACROSS THE GLOBE
4.1.3. GROWING AGED POPULACE
4.1.4. GROWING BIOPHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY
4.1.5. RISING GOVERNMENT SUBSIDY FOR RESEARCH
4.2. RESTRAINTS
4.2.1. LARGE PRIMARY COST DISCOURAGING INVESTMENT
4.2.2. CONCERNS ASSOCIATED WITH INTELLECTUAL PROPERTY AND PATENTS RIGHTS
4.3. MARKET OPPORTUNITY
4.3.1. SINGLE-CELL SEQUENCING (SCS) PROCESS BEING INCREASING USED IN DNA AND RNA ANALYSIS
4.3.2. DEVELOPMENT OF INNOVATIVE MODALITIES
4.3.3. SINGLE-CELL SEQUENCING (SCS) PROCESS BEING INCREASING USED IN DNA AND RNA ANALYSIS
4.3.4. INCREASING INVESTMENT MADE BY THE ASIAN COUNTRIES
4.3.5. ENHANCE OPPORTUNITY IN CANCER CELL RESEARCH
4.4. CHALLENGES
4.4.1. LACK OF ADEQUATE INFRASTRUCTURE
4.4.2. DELAYED ADOPTION OF SINGLE CELL TECHNOLOGY
5. MARKET SEGMENTATION
5.1. BY APPLICATION
5.1.1. MEDICAL APPLICATIONS MARKET
5.1.1.1. CIRCULAR TUMOUR CELLS (CTCS) MARKET
5.1.1.2. NON-INVASIVE PRENATAL DIAGNOSIS MARKET
5.1.1.3. IN VITRO FERTILIZATION (IVF) MARKET
5.1.2. RESEARCH APPLICATIONS MARKET
5.1.2.1. CANCER MARKET
5.1.2.2. IMMUNOLOGY MARKET
5.1.2.3. NEUROLOGY MARKET
5.1.2.4. STEM CELLS MARKET
5.1.2.5. OTHER RESEARCH APPLICATIONS MARKET
5.2. BY TECHNIQUE
5.2.1. FLOW CYTOMETRY MARKET
5.2.2. MASS SPECTROMETRY MARKET
5.2.3. MICROSCOPY MARKET
5.2.3.1. NEXT-GENERATION SEQUENCING (NGS) MARKET
5.2.3.2. PCR (POLYMERASE CHAIN REACTION) MARKET
5.2.3.3. OTHER TECHNIQUES MARKET
5.3. BY CELL TYPE
5.3.1. ANIMAL CELLS MARKET
5.3.2. HUMAN CELLS MARKET
5.3.3. MICROBIAL CELLS MARKET
5.4. BY END USER
5.4.1. BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET
5.4.2. CELL BANKS AND IVF CENTERS MARKET
5.4.3. HOSPITALS AND DIAGNOSTICS LABORATORIES MARKET
5.4.4. RESEARCH & ACADEMIC LABORATORIES MARKET
5.5. BY PRODUCT
5.5.1. CONSUMABLE MARKET
5.5.1.1. ASSAY KITS MARKET
5.5.1.2. BEADS MARKET
5.5.1.3. MICRO PLATES MARKET
5.5.1.4. REAGENTS MARKET
5.5.1.5. OTHER CONSUMABLES MARKET
5.5.2. INSTRUMENT MARKET
5.5.2.1. CELL COUNTER MARKET
5.5.2.2. CELL MICROARRAYS MARKET
5.5.2.3. FLOW CYTOMETERS MARKET
5.5.2.4. HCS SYSTEMS MARKET
5.5.2.5. MICROSCOPES
5.5.2.6. OTHER INSTRUMENTS
6. KEY ANALYTICS
6.1. PORTER’S FIVE FORCE MODEL
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE PRODUCT
6.1.3. BARGAINING POWER OF BUYERS
6.1.4. BARGAINING POWER OF SUPPLIERS
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. PESTEL ANALYSIS
6.3. OPPORTUNITY MATRIX
6.4. KEY BUYING CRITERIA
6.4.1. PRICING
6.4.2. EFFICACY
6.4.3. ACCURACY
6.4.4. APPLICATION AND EFFECTIVENESS
6.5. STRATEGIC RECOMMENDATION & STRATEGIC CONCLUSIONS
6.6. VENDOR LANDSCAPE
6.7. VALUE CHAIN ANALYSIS
7. REGIONAL ANALYSIS
7.1. EUROPE SINGLE CELL ANALYSIS MARKET
7.1.1. UNITED KINGDOM (UK) SINGLE CELL ANALYSIS MARKET
7.1.2. FRANCE SINGLE CELL ANALYSIS MARKET
7.1.3. GERMANY SINGLE CELL ANALYSIS MARKET
7.1.4. SPAIN SINGLE CELL ANALYSIS MARKET
7.1.5. ITALY SINGLE CELL ANALYSIS MARKET
7.1.6. ROE SINGLE CELL ANALYSIS MARKET
8. COMPETITIVE LANDSCAPE
8.1. MARKET SHARE ANALYSIS
8.2. TOP WINNING STRATEGIES
9. COMPANY PROFILES
9.1. CORNING INC.
9.1.1. OVERVIEW
9.1.2. PRODUCT PORTFOLIO
9.1.3. SCOT ANALYSIS
9.1.4. STRATEGIC ANALYSIS
9.2. CELGENE CORPORATION
9.2.1. OVERVIEW
9.2.2. PRODUCT PORTFOLIO
9.2.3. STRATEGIC INITIATIVES
9.2.4. SCOT ANALYSIS
9.2.5. STRATEGIC ANALYSIS
9.3. ILLUMINA INC.
9.3.1. OVERVIEW
9.3.2. PRODUCT PORTFOLIO
9.3.3. STRATEGIC INITIATIVE
9.3.4. SCOT ANALYSIS
9.3.5. STRATEGIC ANALYSIS
9.4. MILTENYI BIOTEC
9.4.1. OVERVIEW
9.4.2. PRODUCT PORTFOLIO
9.4.3. STRATEGIC INITIATIVES
9.4.4. SCOT ANALYSIS
9.4.5. STRATEGIC ANALYSIS
9.5. NANOSTRING TECHNOLOGIESINC
9.5.1. OVERVIEW
9.5.2. PRODUCT PORTFOLIO
9.5.3. STRATEGIC INITIATIVE
9.5.4. SCOT ANALYSIS
9.5.5. STRATEGIC ANALYSIS
9.6. AGILENT TECHNOLOGY INC
9.6.1. OVERVIEW
9.6.2. PRODUCT PORTFOLIO
9.6.3. STRATEGIC INITIATIVESCOT
9.6.4. ANALYSIS
9.6.5. STRATEGIC ANALYSIS
9.7. GE HEALTHCARE
9.7.1. OVERVIEW
9.7.2. PRODUCT PORTFOLIO
9.7.3. STRATEGIC INITIATIVES
9.7.4. SCOT ANALYSIS
9.7.5. STRATEGIC ANALYSIS
9.8. BECKMAN COULTER, INC.
9.8.1. OVERVIEW
9.8.2. PRODUCT PORTFOLIO
9.8.3. SCOT ANALYSIS
9.8.4. STRATEGIC ANALYSIS
9.9. MEDTRONIC’S PLC
9.9.1. OVERVIEW
9.9.2. PRODUCT PORTFOLIO
9.9.3. STRATEGIC INITIATIVE
9.9.4. SCOT ANALYSIS
9.9.5. STRATEGIC ANALYSIS
9.10. STRYKER CORPORATION
9.10.1. OVERVIEW
9.10.2. PRODUCT PORTFOLIO
9.10.3. SCOT ANALYSIS
9.10.4. STRATEGIC ANALYSIS
9.11. THERMO FISHER SCIENTIFIC, INC.
9.11.1. OVERVIEW
9.11.2. PRODUCT PORTFOLIO
9.11.3. STRATEGIC INITIATIVE
9.11.4. SCOT ANALYSIS
9.11.5. STRATEGIC ANALYSIS
9.12. QIAGEN N V
9.12.1. OVERVIEW
9.12.2. PRODUCT PORTFOLIO
9.12.3. SCOT ANALYSIS
9.12.4. STRATEGIC ANALYSIS
9.13. BECKTON DICKINSON AND COMPANY
9.13.1. OVERVIEW
9.13.2. PRODUCT PORTFOLIO
9.13.3. SCOT ANALYSIS
9.13.4. STRATEGIC ANALYSIS
9.14. STEM CELL TECHNOLOGIES
9.14.1. OVERVIEW
9.14.2. PRODUCT PORTFOLIO
9.14.3. STRATEGIC INITIATIVES
9.14.4. SCOT ANALYSIS
9.14.5. STRATEGIC ANALYSIS
TABLE LIST
TABLE 1 EUROPE SINGLE CELL ANALYSIS MARKET BY APPLICATION 2017-2025($ MILLION)
TABLE 2 EUROPE SINGLE CELL ANALYSIS MARKET BY MEDICAL APPLICATIONS 2017-2025($ MILLION)
TABLE 3 EUROPE CTCS MARKET BY 2017-2025($ MILLION)
TABLE 4 EUROPE NIPT MARKET BY 2017-2025($ MILLION)
TABLE 5 EUROPE IVF MARKET BY 2017-2025($ MILLION)
TABLE 6 EUROPE SINGLE CELL ANALYSIS MARKET BY RESEARCH APPLICATIONS, 2017-2025($ MILLION)
TABLE 7 EUROPE SINGLE CELL ANALYSIS MARKET BY RESEARCH APPLICATIONS, 2017-2025($ MILLION)
TABLE 8 EUROPE CANCER MARKET BY 2017-2025($ MILLION)
TABLE 9 EUROPE IMMUNOLOGY MARKET BY 2017-2025($ MILLION)
TABLE 10 EUROPE NEUROLOGY MARKET BY 2017-2025($ MILLION)
TABLE 11 EUROPE STEM CELLS MARKET BY 2017-2025($ MILLION)
TABLE 12 EUROPE OTHER RESEARCH APPLICATIONS MARKET BY 2017-2025($ MILLION)
TABLE 13 EUROPE SINGLE CELL ANALYSIS MARKET BY TECHNIQUE 2017-2025($ MILLION)
TABLE 14 EUROPE FLOW CYTOMETRY MARKET BY 2017-2025($ MILLION)
TABLE 15 EUROPE MASS SPECTROMETRY MARKET BY 2017-2025($ MILLION)
TABLE 16 EUROPE MICROSCOPY MARKET 2017-2025($ MILLION)
TABLE 17 EUROPE MICROSCOPY MARKET BY 2017-2025($ MILLION)
TABLE 18 EUROPE NEXT GENERATION SEQUENCING MARKET BY 2017-2025($ MILLION)
TABLE 19 EUROPE PCR MARKET BY 2017-2025($ MILLION)
TABLE 20 EUROPE OTHER TECHNIQUES MARKET BY 2017-2025($ MILLION)
TABLE 21 EUROPE SINGLE CELL ANALYSIS MARKET BY CELL TYPE 2017-2025($ MILLION)
TABLE 22 EUROPE ANIMAL CELL MARKET 2017-2025($ MILLION)
TABLE 23 EUROPE HUMAN CELL MARKET 2017-2025($ MILLION)
TABLE 24 EUROPE MICROBIAL CELL MARKET 2017-2025($ MILLION)
TABLE 25 EUROPE BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET 2017-2025($ MILLION)
TABLE 26 EUROPE CELL BANKS AND IVF CENTERS MARKET 2017-2025($ MILLION)
TABLE 27 EUROPE HOSPITALS AND DIAGNOSTICS LABORATORIES MARKET 2017-2025($ MILLION)
TABLE 28 EUROPE RESEARCH & ACADEMIC LABORATORIES MARKET 2017-2025($ MILLION)
TABLE 29 EUROPE SINGLE CELL ANALYSIS MARKET BY PRODUCTS 2017-2025($ MILLION)
TABLE 30 EUROPE SINGLE CELL ANALYSIS BY CONSUMABLE MARKET 2017-2025($ MILLION)
TABLE 31 EUROPE SINGLE CELL ANALYSIS MARKET BY ASSAY KITS 2017-2025($ MILLION)
TABLE 32 EUROPE SINGLE CELL ANALYSIS MARKET BY BEADS 2017-2025($ MILLION)
TABLE 33 EUROPE SINGLE CELL ANALYSIS MARKET BY MICROPLATES 2017-2025($ MILLION)
TABLE 34 EUROPE SINGLE CELL ANALYSIS MARKET BY REAGENTS 2017-2025($ MILLION)
TABLE 35 EUROPE SINGLE CELL ANALYSIS MARKET BY OTHER CONSUMABLES 2017-2025($ MILLION)
TABLE 36 EUROPE SINGLE CELL ANALYSIS BY CONSUMABLE MARKET 2017-2025($ MILLION)
TABLE 37 EUROPE SINGLE CELL ANALYSIS MARKET BY CELL COUNTER 2017-2025($ MILLION)
TABLE 38 EUROPE SINGLE CELL ANALYSIS MARKET BY CELL MICROARRAY 2017-2025($ MILLION)
TABLE 39 EUROPE SINGLE CELL ANALYSIS MARKET BY FLOW CYTOMETRY 2017-2025($ MILLION)
TABLE 40 EUROPE SINGLE CELL ANALYSIS MARKET BY MICROSCOPES 2017-2025($ MILLION)
TABLE 41 EUROPE SINGLE CELL ANALYSIS MARKET BY OTHER INSTRUMENTS 2017-2025($ MILLION)
FIGURE LIST
FIGURE 1 EUROPE SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 2 MARKET BREAKUP BY REVENUE IN 2016
FIGURE 3 NIH SPENDING ON STEM CELL, BY YEARS (USD BILLIONS)
FIGURE 4 EUROPE SINGLE CELL ANALYSIS MARKET BY CTCS 2017-2025($ MILLION)
FIGURE 5 EUROPE SINGLE CELL ANALYSIS MARKET BY NIPT 2017-2025($ MILLION)
FIGURE 6 EUROPE SINGLE CELL ANALYSIS MARKET BY IVF 2017-2025($ MILLION)
FIGURE 7 EUROPE SINGLE CELL ANALYSIS MARKET BY CANCER 2017-2025($ MILLION)
FIGURE 8 EUROPE SINGLE CELL ANALYSIS MARKET BY IMMUNOLOGY 2017-2025($ MILLION)
FIGURE 9 EUROPE SINGLE CELL ANALYSIS MARKET BY NEUROLOGY 2017-2025($ MILLION)
FIGURE 10 EUROPE SINGLE CELL ANALYSIS MARKET BY STEM CELLS 2017-2025($ MILLION)
FIGURE 11 EUROPE SINGLE CELL ANALYSIS MARKET BY OTHER RESEARCH APPLICATIONS 2017-2025($ MILLION)
FIGURE 12 EUROPE SINGLE CELL ANALYSIS MARKET BY FLOW CYTOMETRY 2017-2025($ MILLION)
FIGURE 13 EUROPE SINGLE CELL ANALYSIS MARKET BY MASS SPECTROMETRY 2017-2025($ MILLION)
FIGURE 14 EUROPE SINGLE CELL ANALYSIS MARKET BY MICROSCOPY 2017-2025($ MILLION)
FIGURE 15 EUROPE SINGLE CELL ANALYSIS MARKET BY NEXT GENERATION SEQUENCING 2017-2025($ MILLION)
FIGURE 16 EUROPE SINGLE CELL ANALYSIS MARKET BY PCR 2017-2025($ MILLION)
FIGURE 17 EUROPE SINGLE CELL ANALYSIS MARKET BY OTHER TECHNIQUES 2017-2025($ MILLION)
FIGURE 18 EUROPE ANIMAL CELL MARKET 2017-2025($ MILLION)
FIGURE 19 EUROPE HUMAN CELL MARKET 2017-2025($ MILLION)
FIGURE 20 EUROPE NEW CANCER CASES AND MOTILITY RATE IN MILLION (2015-2030)
FIGURE 21 EUROPE MICROBIAL CELL MARKET 2017-2025($ MILLION)
FIGURE 22 EUROPE BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET 2017-2025($ MILLION)
FIGURE 23 EUROPE CELL BANKS AND IVF CENTERS MARKET
FIGURE 24 EUROPE HOSPITALS AND DIAGNOSTICS LABORATORIES MARKET 2017-2025($ MILLION)
FIGURE 25 EUROPE RESEARCH & ACADEMIC LABORATORIES MARKET 2017-2025($ MILLION)
FIGURE 26 EUROPE SINGLE CELL ANALYSIS MARKET BY ASSAY KITS 2017-2025($ MILLION)
FIGURE 27 EUROPE SINGLE CELL ANALYSIS MARKET BY BEADS 2017-2025($ MILLION)
FIGURE 28 EUROPE SINGLE CELL ANALYSIS MARKET BY MICROPLATES 2017-2025($ MILLION)
FIGURE 29 EUROPE SINGLE CELL ANALYSIS MARKET BY REGENTS 2017-2025($ MILLION)
FIGURE 30 EUROPE SINGLE CELL ANALYSIS MARKET BY OTHER CONSUMABLES 2017-2025($ MILLION)
FIGURE 31 EUROPE SINGLE CELL ANALYSIS MARKET BY CELL COUNTER 2017-2025($ MILLION)
FIGURE 32 EUROPE SINGLE CELL ANALYSIS MARKET BY CELL MICROARRAY 2017-2025($ MILLION)
FIGURE 33 EUROPE SINGLE CELL ANALYSIS MARKET BY FLOW CYTOMETRY 2017-2025($ MILLION)
FIGURE 34 EUROPE SINGLE CELL ANALYSIS MARKET BY HCS SYSTEM 2017-2025($ MILLION)
FIGURE 35 EUROPE SINGLE CELL ANALYSIS MARKET BY MICROSCOPES 2017-2025($ MILLION)
FIGURE 36 EUROPE SINGLE CELL ANALYSIS MARKET BY OTHER INSTRUMENTS 2017-2025($ MILLION)
FIGURE 37 REVENUE OF DIAGNOSTIC & MEDICAL LABORATORIES IN THE US, 2014-16 (BILLIONS)
FIGURE 38 NUMBER OF PEOPLE LIVING WITH HIV IN 2015 EUROPELY (MILLIONS)
FIGURE 39 UNITED KINGDOM SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 40 ESTIMATED WHO REGIONAL TB STATISTICS FOR 2015
FIGURE 41 FRANCE SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 42 GERMANY SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 43 PERCENTAGE OF PEOPLE OVER 65 YEARS OF AGE (SPAIN)
FIGURE 44 SPAIN SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 45 ITALY SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 46 ROE SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
